The U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) to permit the emergency use of the unapproved product, Pfizer-BioNTech COVID-19 Vaccine, for active immunization to prevent C O VID-19 in individuals 16 years of age and older.

Download the FDA Summary of Instructions pdf, Page 7 of 29 contains a list of possible adverse reactions.